Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127913) titled 'Establishment and Clinical Study of an AI-Driven Multi-Omics Multi-Modal Intrahepatic Cholangiocarcinoma Subtyping System' on July 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Condition:
Intrahepatic cholangiocarcinoma (ICC)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Observation group:350;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=316564
Published by HT Digital Content Services with perm...